L. Gianni

1. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
   2021/07/01 by David Miles, F. André, Fabrice André +242 · 3 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Advanced Breast Cancer Therapies #Breast Cancer Treatment Studies #Cancer Immunotherapy and Biomarkers
2. Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
   2022/02/16 by Luca Gianni, L. Gianni, Chiun‐Sheng Huang +35 · 2 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #Cancer Immunotherapy and Biomarkers #HER2/EGFR in Cancer Research